| Literature DB >> 6240401 |
M L Smith, W Martin, J H McKillop, I Fogelman.
Abstract
In two patients with metastatic disease more lesions were detected on scintigraphs obtained with the 'low uptake' bone-scanning agent dimethyl-amino-diphosphonate. The results in these two patients provide practical support for the suggestion that bone-scanning agents with low uptake in normal bone, but high tumour-to-normal bone ratios, will allow better delineation of focal bone abnormalities.Entities:
Mesh：
Substances：
Year: 1984 PMID： 6240401 DOI： 10.1007/bf00263258
Source DB: PubMed Journal: Eur J Nucl Med ISSN： 0340-6997